Judge Rules For Sanofi, Bristol-Myers In Plavix Case
The two pharmaceutical giants co-market Plavix, a blood thinner.
The appeals court has set an expedited schedule for Apotex's appeal of the preliminary injunction, with oral argument scheduled for Oct. 31.
Bristol-Myers and Sanofi-Aventis had argued that lifting the injunction would “inflict further, profound damage upon a patent that the...
To view the full article, register now.